Clinical Trial Update: A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase III study comparing glofitamab plus gemcitabine and oxaliplatin versus rituximab plus gemcitabine and oxaliplatin in relapsed/refractory diffuse large B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Glofitamab (glofitamab)
• OXALIPLATIN (Oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diffuse Large B-cell Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING